New lessons learned from cancer immunotherapy: tumor-specific CD4+T cells frequently expand and react to short peptides

被引：0
|
作者：
Gross, S. [1 ]
Hamann, A. [1 ]
Leisgang, W. [1 ]
Schuler-Thurner, B. [1 ]
Schuler, G. [1 ]
Kaempgen, E. [1 ]
机构：
[1] Univ Hosp Erlangen, Dept Dermatol, D-91052 Erlangen, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2011年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P148
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [21] Alkylating Agent Melphalan Augments the Efficacy of Adoptive Immunotherapy Using Tumor-Specific CD4+ T Cells
    Lu, Xiaoyun
    Ding, Zhi-Chun
    Cao, Yang
    Liu, Chufeng
    Habtetsion, Tsadik
    Yu, Miao
    Lemos, Henrique
    Salman, Huda
    Xu, Hongyan
    Mellor, Andrew L.
    Zhou, Gang
    JOURNAL OF IMMUNOLOGY, 2015, 194 (04): : 2011 - 2021
  • [22] Tumor-specific CD8+Tc9 cells activate host CD4+T cells to control antigen-lost tumors
    Xiao, Liuling
    Yi, Qing
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
    Tay, Rong En
    Richardson, Emma K.
    Toh, Han Chong
    CANCER GENE THERAPY, 2021, 28 (1-2) : 5 - 17
  • [24] Ocular melanoma cells genetically modified to express HLA-DR and CD80 activate tumor-specific CD4+T cells
    Bosch, Jacobus J.
    Thompson, James A.
    Dissanayake, Samudra K.
    Ksander, Bruce R.
    Ostrand-Rosenberg, Suzanne
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S258 - S258
  • [25] Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
    Cachot, Amelie
    Bilous, Mariia
    Liu, Yen-Cheng
    Li, Xiaokang
    Saillard, Margaux
    Cenerenti, Mara
    Rockinger, Georg Alexander
    Wyss, Tania
    Guillaume, Philippe
    Schmidt, Julien
    Genolet, Raphael
    Ercolano, Giuseppe
    Protti, Maria Pia
    Reith, Walter
    Ioannidou, Kalliopi
    de Leval, Laurence
    Trapani, Joseph A.
    Coukos, George
    Harari, Alexandre
    Speiser, Daniel E.
    Mathis, Alexander
    Gfeller, David
    Altug, Hatice
    Romero, Pedro
    Jandus, Camilla
    SCIENCE ADVANCES, 2021, 7 (09):
  • [26] Cytokine profile of successful cancer immunosurveillance mediated by tumor-specific CD4+ T cells
    Haabeth, Ole Audun Werner
    Lorvik, Kristina Berg
    Bogen, Bjarne
    Corthay, Alexandre
    CYTOKINE, 2009, 48 (1-2) : 48 - 48
  • [27] Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
    Baxevanis, CN
    Voutsas, IF
    Tsitsilonis, OE
    Gritzapis, AD
    Sotiriadou, R
    Papamichail, M
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3902 - 3912
  • [28] Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk
    Benigni, F
    Zimmermann, VS
    Hugues, S
    Caserta, S
    Basso, V
    Rivino, L
    Ingulli, E
    Malherbe, L
    Glaichenhaus, N
    Mondino, A
    JOURNAL OF IMMUNOLOGY, 2005, 175 (02): : 739 - 748
  • [29] IL11: A Specific Repressor of Tumor-Specific CD4+ T Cells
    van der Burg, Sjoerd H.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (07) : 724 - 724
  • [30] Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity
    Guy, Thomas V.
    Terry, Alexandra M.
    Bolton, Holly A.
    Hancock, David G.
    Zhu, Erhua
    Brink, Robert
    McGuire, Helen M.
    Shklovskaya, Elena
    Fazekas de St Groth, Barbara
    ONCOTARGET, 2016, 7 (21) : 30211 - 30229
12345